Personalized cell therapy with MSCs is safe and leads to clear improvements in clinical aspects and quality of life for patients with complete and chronically established paraplegia.
Source: Summary of Website
Identification
Bibliographic data
Author
Place of publication
London
Magazine
Cytotherapy
Volume
18
Issue
8
Retrieved
Year
2016
Month
August
Pages
1025-1036
Language
English
Additional Information
Source
AT Observatory